Picture of BioVie logo

BIVI BioVie Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for BioVie, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2017
June 30th
2018
June 30th
2019
June 30th
2020
June 30th
2021
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue00000
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1.552.372.52.69138
Operating Profit-1.55-2.37-2.5-2.69-138
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1.33-2.41-2.44-16.7-130
Net Income After Taxes-1.33-2.41-2.44-16.7-130
Net Income Before Extraordinary Items
Net Income-1.33-2.41-2.44-16.7-130
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1.33-2.43-2.49-33.8-184
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1.86-3.18-0.982-6.85-14.8
Dividends per Share

Or unlock with your email

Or unlock with your email